![Spacer](https://webarchive.library.unt.edu/eot2008/20090117044737im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117044737im_/http://www.fda.gov/cvm/Images/dot_clear.gif)
Table of Contents
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117044737im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117044737im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are used to control the pain and inflammation associated with osteoarthritis. Inflammation - the body’s response to irritation or injury - is characterized by redness, warmth, swelling, and pain. NSAIDs work by blocking the production of prostaglandins, the body chemicals that cause inflammation.
In veterinary medicine approved veterinary NSAIDs are used to control the pain of osteoarthritis in dogs and some veterinary NSAIDs are approved for the control of postoperative pain in dogs. However, there are risks and benefits with all commonly prescribed veterinary drugs, including NSAIDs. Veterinarians and pet owners should be aware of the following facts:
-
Oral NSAIDs are approved for use in dogs only.
-
All dogs should undergo a thorough history and physical examination before beginning NSAID therapy.
-
Appropriate blood/urine tests should be performed to establish baseline data prior to, and periodically during, administration of any NSAID.
-
Veterinary NSAIDS may be associated with gastrointestinal ulcers/perforations, liver, and kidney toxicity.
-
Use with other anti-inflammatory drugs, such as other NSAIDs and corticosteroids, should be avoided.
-
Patients at greatest risk for kidney problems are those that are dehydrated, are on diuretic treatment, or have pre-existing kidney, heart, and/or liver problems.
-
NSAIDs can cause stomach or intestinal bleeding.
Risks associated with NSAIDs are detailed on the package inserts and Client Information Sheets.
CVM Updates
NSAIDs Brochure
Guidance Documents
-
Guidance for Industry 123 - Development of Target Animal Safety and Effectiveness Data to Support Approval of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) for Use in Animals, Final, January 5, 2006 | html | | doc | | pdf | FR Notice
Current Labels – selected current labels including labels of several NSAIDs
Adverse Drug Experience Reporting - these reports include domestic adverse drug experience reports submitted to CVM that CVM has determined to be at least "possibly" drug related.
Additional Information
-
Pain Drugs for Dogs: Be an Informed Pet Owner , FDA Consumer Magazine, September-October 2006
-
What Veterinarians Should Tell Clients About Pain Control and Their Pets – FDA Veterinarian Newsletter, 2006, Vol. XXI, No. I
-
Advice to Dog Owners Whose Pets Take NSAIDs – FDA Veterinarian Newsletter, 2006, Vol. XXI, No. I
-
Moskal TJ, Minimizing the risk factors associated with veterinary NSAIDS. J Am Vet Med Assoc., 2004 Apr 15; 224(8):1231-1232
-
Hampshire VA, Emerging issues regarding informed consent. J Am Vet Med Assoc., 2004 Jan 15; 224(2):177
Web Page Updated by mdt - January 3, 2008, 12:11 PM ET
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090117044737im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |